/
Why Health Information Standards Why Health Information Standards

Why Health Information Standards - PDF document

joy
joy . @joy
Follow
342 views
Uploaded On 2021-06-07

Why Health Information Standards - PPT Presentation

Organisation HISO has endorsed GS1 standards for New Zealand healthcare Richard Medlicott Chairperson HISO Standards source Underpinning Patient Safety recommendations guidelines for pro ID: 836861

hiso standards endorsement product standards hiso product endorsement identification patient automated data consultation relevant bodies stakeholders subject health gs1

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "Why Health Information Standards" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1 Why Health Information Standards Organi
Why Health Information Standards Organisation (HISO) has endorsed GS1 standards for New Zealand healthcare Richard Medlicott. Chairperson. HISO. Standards ( source: Underpinning Patient Safety - recommendations

2 & guidelines for product coding withi
& guidelines for product coding within the UK Pharmaceutical Supply Chain (Dec 2004) Improved Patient Safety • Reducing medication errors • Right product, right patient, right dose, right time, right route Anti -

3 counterfeiting/ Traceability Benefits
counterfeiting/ Traceability Benefits • EPC/ RFID based on GS1 numbering structures Operational Efficiency Gains • Transparency & traceability – Improved visibility • Linkage to electronic patient record E

4 conomic Gains • Reduced waste, adve
conomic Gains • Reduced waste, adverse events, product availability Benefits of Coding Standards Global NZ UK Australia Population (million) 4.4 62 22 GDP ($US billion) 127 2250 925 Pharma c

5 eutic al Budget (Public) ($US billi
eutic al Budget (Public) ($US billion) 0.86 17 6.5 Pharms cost per person ($US) 195 274 295 HISO - Health Information Standards Organisation endorse GS1 Standards GS1 endorsement At the 1

6 7 August 2011 meeting, the HIS
7 August 2011 meeting, the HISO ( 2010 ) committee endorsed the GS 1 standards for automated product identification for all pharmaceutical products and supplies including data carr

7 iers (barcodes), the Global Trad
iers (barcodes), the Global Trade Identification Number (GTIN) product identifier and other associated data definitions . HISO will consider full endorsement of the GS 1 stand

8 ards for automated product ident
ards for automated product identification for all medical devices and equipment following consultation with the relevant bodies and stakeholders, and subject to the recommendations

9 that come from this . This w
that come from this . This will include reference to decisions made in other significant jurisdictions such as the USA Food and Drug Administration (FDA) . HISO also su

10 pports use of the GS 1 standar
pports use of the GS 1 standards in a National Product Catalogue , again subject to appropriate consultation and agreement with relevant bodies and stakeholders . At the 17 A

11 ugust 2011 meeting, the HISO (
ugust 2011 meeting, the HISO ( 2010 ) committee endorsed the GS 1 standards for automated product identification for all pharmaceutical products and supplies including data carriers

12 (barcodes), the Global Trade I
(barcodes), the Global Trade Identification Number (GTIN) product identifier and other associated data definitions . HISO Endorsement Part 1 National Health IT Plan Health Quality and Safety Co

13 mmission HISO will consider full
mmission HISO will consider full endorsement of the GS 1 standards for automated product identification for all medical devices and equipment following consultation with the releva

14 nt bodies and stakeholders, and
nt bodies and stakeholders, and subject to the recommendations that come from this . This will include reference to decisions made in other significant jurisdictions such as t

15 he USA Food and Drug Administr
he USA Food and Drug Administration (FDA) . HISO Endorsement Part 2 HISO also supports use of the GS 1 standards in a National Product Catalogue , again subject to appropriate

16 consultation and agreement with
consultation and agreement with relevant bodies and stakeholders . HISO Endorsement Part 3 We are about saving New Zealanders lives, and stripping the costs out of healthcare delivery. Number One .